share_log

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

安进的股票在其与MariTide针对肥胖的二期研究结果公布后,交易价格下跌。
Benzinga ·  20:50

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

安进的股票在其与MariTide针对肥胖的二期研究结果公布后,交易价格下跌。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发